Publication | Closed Access

The Rho-kinase inhibitor, fasudil, attenuates diabetic nephropathy in streptozotocin-induced diabetic rats

Metabolic SyndromeMedicineDiabetesPhysiologyPharmacologyDiabetic Kidney DiseaseDiabetic NephropathyRho-kinase InhibitorDiabetes MellitusChronic Kidney DiseaseStreptozotocin-induced Diabetic RatsNephrologyOxidative StressHealth Sciences